Kenneth Carter – PESI – Psychopharmacology in Plain English: 2-Day Conference

Description

Psychopharmacology in Plain English: 2-Day Conference download , Kenneth Carter – PESI – Psychopharmacology in Plain English: 2-Day Conference review, Kenneth Carter – PESI – Psychopharmacology in Plain English: 2-Day Conference free

Kenneth Carter – PESI – Psychopharmacology in Plain English: 2-Day Conference

Clear, Concise, and Current Information on Psychotropic Medications

Does this sound familiar? Your clients are taking multiple psychotropic medications prescribed by different health care professionals. You watch as prescriptions stream in from psychiatrists, family physicians, nurse practitioners, and others, and you discover that your clients have no idea who wrote which prescription or why they are even taking the medication. You realize that despite the confusion, you still have a responsibility to know your clients’ symptoms and reactions to medications, and to coordinate their care.

In this recording, Dr. Kenneth Carter goes further in depth with practical and useful information that you need to advocate for your clients. You will get the latest information on antidepressants, anti-anxiety medications, medications for insomnia, and others. You will dive deeper into the ethical decisions that accompany their use. After this of dynamic training, you will leave better prepared to communicate with your clients as well as the prescribers, as Dr. Carter instructs you on how the medications work, their benefits, and the side effects and dangerous reactions associated with them.

Speaker

Kenneth Carter, PhD, ABPP

Kenneth Carter, PhD, ABPP, is a board-certified clinical psychologist and professor of psychology at Oxford College of Emory University in Atlanta, Georgia. Dr. Carter received his MA and PhD in clinical psychology from the University of Michigan in Ann Arbor and a postdoctoral master’s degree in clinical psychology from Fairleigh Dickerson University. Dr. Carter has taught clinical psychopharmacology classes at Emory University since 2005 and has presented highly rated psychopharmacology workshops to clinicians throughout the United States since 2010. Dr. Carter has served as senior assistant research scientist in the Epidemic Intelligence Service of the Centers for Disease Control and Prevention. He has been a psychotherapist and researcher for more than 20 years during which time he has garnered awards from the National Institutes of Health, the National Heart, Lung and Blood Institute, and the University of Michigan. Dr. Carter has presented at numerous conferences and written several books and articles on introductory psychology, neuropsychology and psychopharmacology.

Speaker Disclosures:
Financial: Dr. Kenneth Carter has employment relationships with Positive Impact Health Centers and Oxford College of Emory University. He is a published author and receives royalties. Dr. Carter receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Kenneth Carter is a member of the American Psychological Association, the Association for Psychological Science, the Neuroscience Education Institute, and the American Association for the Advancement of Science.

Target Audience

• Psychologists
• Psychiatrists
• Social Workers
• Counselors
• Alcoholism and Drug Abuse Counselors
• Nurses
• Nurse Practitioners
• Psychiatric Nurse Practitioners
• Marriage and Family Therapists
• Case Managers

Objectives

1. Analyze the historical antecedents of psychopharmacological products and their relation to today’s psychotropic medications.
2. Designate the mechanism of action of today’s psychotropic medications and how it relates to your clients.
3. Breakdown the process of medication selection and receptor activation/blocking for specific disorders.
4. Communicate the side effects including nutritional, cognitive, sexual, and behavioral associated with psychotropic medications.
5. Specify how medications are chosen for depressive disorders and specific patient characteristics.
6. Compile medication treatment options for your clients with ADHD.
7. Determine the unique medication considerations for geriatric clients.
8. Analyze future trends, including preventing side effects vs. managing side effects.
9. Establish ethical issues specifically relating to the limits of non-prescribers’’ discussion of medications as it relates to clinical psychopharmacology.
10. Explore specific ethical issues and their resolve to the everyday practice of clinical psychopharmacology.

Outline

PSYCHOPHARMACOLOGY ETHICS FOR NON-PRESCRIBERS

• Case Study
• Understanding the challenges of psychopharmacology ethics
• Reasons to be knowledgeable about psychopharmacology
• Ways to increase success with medications
• Lessons from other disciplines
• Understanding the limits of non-prescribers’ discussion of medications
• Ethics codes
• Informed consent and medications
• Common questions clients have about medications
• Guidelines for discussing medications with clients
• Collaborating with prescribers

PSYCHOPHARMACOLOGY 101

• The terminology of psychopharmacology
• General overview of the nervous system
• Finding your way around the nervous system
• The parts of the neuron
• How neurons communicate
• What the body does to medications
• What medications do to the body
• Receptors and Ligands
• Routes of administration for medications
• Drug-drug interactions
• Understanding genetic testing

DEPRESSIVE DISORDERS

• Neurobiology of depressive disorders
• Medications for depressive disorders

ANXIETY AND RELATED DISORDERS

• Disorders with anxiety components
• Neurobiology of anxiety disorders
• Medications for anxiety disorders

PSYCHOTIC DISORDERS

• Neurobiology of psychotic disorders
• Medications for psychotic disorders

BIPOLAR DISORDERS

• Neurobiology of bipolar disorders
• Medications for bipolar disorders

ATTENTION DEFICIT HYPERACTIVITY DISORDER

• ADHD diagnostic criteria and basic concepts
• Neurobiology of ADHD
• Medications for ADHD
• Medication delivery systems for ADHD

INSOMNIA

• Sleep and insomnia concepts
• Neurobiology of insomnia
• Medications for insomnia

PHARMACOTHERAPY OF SPECIAL POPULATIONS

• Children
• Geriatric psychopharmacology
• ComorbidityCommonly Asked Questions:
  1. Business Model Innovation: Acknowledge the reality of a legitimate enterprise! Our approach involves the coordination of a collective purchase, in which the costs are shared among the participants. We utilize this cash to acquire renowned courses from sale pages and make them accessible to individuals with restricted financial resources. Our clients appreciate the affordability and accessibility we provide, despite the authors’ concerns.
  2. Psychopharmacology in Plain English: 2-Day Conference Course
  • There are no scheduled coaching calls or sessions with the author.
  • Access to the author’s private Facebook group or web portal is not permitted.
  • No access to the author’s private membership forum.
  • There is no direct email support available from the author or their team.